Undiagnosed tuberculosis in a community with high HIV prevalence: Implications for tuberculosis control

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 1, 2007, Pages 87-93

  Wood, Robin ^b   Middelkoop, Keren ^b   Myer, Landon ^b   Grant, Alison D ^b   Whitelaw, Andrew ^b   Lawn, Stephen D ^b   Kaplan, Gilla ^b   Huebner, Robin ^b   McIntyre, James ^b   Bekker, Linda Gail ^a  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b NONE

Author keywords

African community; Case finding; HIV infection; Incidence and prevalence; Pulmonary tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL FEATURE; COMMUNITY CARE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE DURATION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCREENING TEST; SPUTUM CYTODIAGNOSIS;

ADOLESCENT; ADULT; COMMUNICABLE DISEASE CONTROL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

EID: 33846222408     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200606-759OC     Document Type: Article

References (43)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: World Health Organization; 2005. WHO Report No. WHO/HTM/TB/2005.349.
2. World Health Organization. WHO declares TB an emergency in Africa: call for "urgent and extraordinary actions" to halt a worsening epidemic. September 2, 2005. Available from: http://www.who.int/mediacentre/news/ africa_emergency/en/ (accessed September 6, 2005).
3. China Tuberculosis Control Program. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996;350:169-172.
4. Netto EM, Dye C, Raviglione M. Progress in tuberculosis control 1995-1996, with emphasis on 22 high-income countries. Int J Tuberc Lung Dis 1999;3:310-320.
5. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. The effect of directly observed therapy on the rates of drug resistance and relapses in tuberculosis. N Engl J Med 1994;330:1179-1184.
6. Maher D, Borgdorff M, Boerma T. HIV-related tuberculosis: how well are we doing with current control efforts? Int J Tuberc Lung Dis 2005;9:17-24.
7. Whalen CC. Failure of directly observed treatment for tuberculosis in Africa: a call for new approaches. Clin Infect Dis 2006;42:1048-1050.
8. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006;367:926-937.
9. Brindle RJ, Nunn PP, Githi W, Allen BW, Gathua S, Waiyaki P. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 1993;147:948-961.
10. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, UK: Oxford University Press; 1991. pp. 13-26.
11. Archibald LK, den Dulk MO, Pallangyo KJ, Reller LB. Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis 1998;26:290-296.
12. Banda HT, Harries AD, Welby S, Boeree MJ, Wirima JJ, Subramanyam VR, Maher D, Nunn PA. Prevalence of tuberculosis in TB suspects with short duration of cough. Trans R Soc Trop Med Hyg 1998;92:161-163.
13. Mwachari C, Batchelor BI, Paul J, Waiyaki PG, Gilks CF. Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya. J Infect 1998;37:48-53.
14. Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, Cole BF, Vuola JM, Tvaroha S, Kreisworth B, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005;40:1500-1507.
15. Corbett EL, Charalambous S, Moloi VM, Fielding K, Grant A, Dye C, De Cock KM, Hayes RJ, Williams BG, Churchyard GJ. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004;170:673-679.
16. Godfrey-Faussett P, Sonnenberg P, Shearer S, Bruce MC, Mee C, Morris L, Murray J. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet 2000;356:1066-1071.
17. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study Lancet 2002;359:2059-2064.
18. Glynn JR, Crampin AC, Ngwira BM, Mwaungulu FD, Mwafulirwa DT, Floyd S, Ponnighaus JM, Warndorff DK, Fine PE. Trends in tuberculosis and the influence of HIV-infection in northern Malawi, 1988-2001. AIDS 2004;18:1459-1463.
19. Wood R, Maartens G, Lombard CL. Risk factors for developing tuberculosis in HIV-1 infected adults from communities with a low or very high incidence of tuberculosis. AIDS 2000;23:75-80.
20. Lawn SD, Bekker L-G, Middelkoop K, Myer L, Wood R. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. CID 2006;42:1040-1046.
21. Bekker L-G, Middelkoop K, Myer L, Whitelaw A, Grant A, Kaplan G, Lawn S, Wood R. Prevalence of HIV and undiagnosed tuberculosis in a peri-urban community in South Africa. Presented at the 13th Conference on Retroviruses and Opportunistic Infections, Denver, Colorado, February 5-8, 2006. Abstract No. 69.
22. Levy PS, Lemshow S. Sampling of populations: methods and applications. New York: Wiley Interscience; 1999.
23. The South African Tuberculosis Control Program;Department of Health, South Africa. Practical guidelines 2000. Available from: http://www.doh.gov.za/ tb/docs/ntcpguidelines.pdf (accessed April 5, 2006).
24. De Wit D, Steyn L, Shoemaker S, Sogin M. Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification. J Clin Microbiol 1990;28:2437-2441.
25. Fleiss JL, Levin B, Cho Paik M. Statistical methods for rates and proportions, 3rd edition. New York: Wiley Science; 2003.
26. World Health Organization. Framework for effective tuberculosis control. Geneva, Switzerland; World Health Organization; 1994. WHO Document No. WHO/TB/94.179.
27. Elliott AM, Hayes RJ, Halwindii B, Luo N, Tembo G, Pobee JO, Nunn PP, McAdam KP. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS 1993;7:981-987.
28. Pronyk PM, Joshi B, Hargreaves JR, Madonsela T, Collinson MA, Mokoena O, Tollman SM, Hausler HR. Active case finding: understanding the burden of tuberculosis in rural South Africa. Int J Tuberc Lung Dis 2001;5:611-618.
29. Tuberculosis Coalition for Technical Assistance. International standards for tuberculosis care (ISTC). The Hague, Netherlands: Tuberculosis Coalition for Technical Assistance; 2006.
30. Miller LG, Asch S, Yu EI, Knowles L, Gelberg L, Davidson P. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis 2000;30:293-299.
31. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, Nyirenda ST, Binkin NJ, Lucas SB. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 2002;6:55-63.
32. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C, et al. The mortality and pathology of HIV-infection in a West African city. AIDS 1993;7:1569-579.
33. Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, Ng'ang'a LW, Power C, Githui WA, Porter JD, Lucas SB. Autopsy study of HIV-1 positive and HIV-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000;24:23-29.
34. Harries AD, Kamenya A, Subramanyam VR, Maher D, Squire SB, Wirima JJ, Nyangulu DS, Nunn P. Screening pulmonary tuberculosis suspects in Malawi: testing different strategies. Trans R Soc Trop Med Hyg 1997;91:416-419.
35. Hargreaves NJ, Kadzakumanja O, Phiri S, Nyangulu DS, Salaniponi FM, Harries AD, Squire SB. What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence? Int J Tuberc Lung Dis 2001;5:113-122.
36. Apers L, Wijarajah C, Mutsvanga J, Chigara N, Mason P, van der Styft P. Accuracy of routine diagnosis of pulmonary tuberculosis in an area of high HIV prevalence. Int J Tuberc Lung Dis 2004;8:945-951.
37. Centers for Disease Control and Prevention (CDC). Multiple misdiagnoses of tuberculosis resulting from laboratory error - Wisconsin, 1996. MMWR Morb Mortal Wkly Rep 1997;46:797-801.
38. Battacharya M, Dietrich S, Mosher L, Siddiqui F, Reisberg BE, Paul WS, Warren JR. Cross contamination of specimens with Mycobacterium tuberculosis: clinical significance, causes and prevention. Am J Clin Pathol 1998;109:324-330.
39. Cape Metropolitan Council. Townships and informal settlements in the Cape metropolitan region: visual illustration, development, background and present issues. Cape Town, South Africa: Regional Planning, Engineering Service, Cape Metropolitan Council; 1995.
40. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis (TB) in an antiretroviral treatment (ART) service in sub-Saharan Africa: impact on ART outcomes and implications for TB control. AIDS 2006;20:1605-1612.
41. De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999;3:457-465.
42. World Health Organization. Interim policy on collaborative TB/HIV activities. Geneva, Switzerland: World Health Organization; 2004. Available from: http://whqlibdoc.who.int/hq/2004/who_htm_tb_2004.330.pdf (accessed July 4, 2006).
43. World Health Organization. An expanded DOTS framework for effective tuberculosis control. Geneva, Switzerland: World Health Organization; 2002. Publication No. WHO/CDS/TB/2002.297.